Harald Reinhart - 23 Aug 2021 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
Chief Medical Officer
Signature
/s/ Bruce A. Blefeld
Issuer symbol
ZLAB
Transactions as of
23 Aug 2021
Net transactions value
-$1,939,040
Form type
4
Filing time
25 Aug 2021, 17:47:06 UTC
Previous filing
15 Jul 2021
Next filing
08 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZLAB Ordinary Shares Options Exercise $143,920 +8,000 $17.99 8,000 23 Aug 2021 Direct F1
transaction ZLAB Ordinary Shares Sale $1,080,000 -8,000 -100% $135.00* 0 23 Aug 2021 Direct F1
transaction ZLAB Ordinary Shares Options Exercise $143,920 +8,000 $17.99 8,000 24 Aug 2021 Direct F1
transaction ZLAB Ordinary Shares Sale $1,146,880 -8,000 -100% $143.36* 0 24 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8,000 -17% $0.000000 38,000 23 Aug 2021 Ordinary Shares 8,000 $17.99 Direct F1, F2
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8,000 -21% $0.000000 30,000 24 Aug 2021 Ordinary Shares 8,000 $17.99 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant.